Fetal lipoprotein changes in pre-eclampsia.

Area of Science:

• Obstetrics and Gynecology
• Neonatal Health
• Cardiovascular Risk Factors

Background:

• Pre-eclampsia (PE) is a pregnancy complication characterized by high blood pressure.
• Maternal lipid metabolism is altered during pregnancy, and PE may exacerbate these changes.
• The impact of these maternal lipid alterations on fetal development is not fully understood.

Purpose of the Study:

• To investigate the relationship between maternal lipid profiles and fetal lipid profiles in pre-eclamptic pregnancies.
• To compare lipid profiles in maternal blood and umbilical cord blood (UCB) between healthy and pre-eclamptic pregnancies.

Main Methods:

• A case-control study involving 42 healthy and 46 pre-eclamptic pregnancies.
• Measurement of total cholesterol (TChol), HDL-cholesterol (HDLc), LDL-cholesterol (LDLc), triglycerides (TG), apolipoprotein A-I (apoA-I), apolipoprotein B (apoB), and lipoprotein (a) [Lp(a)] in maternal and UCB.
• Analysis of lipid profiles using enzymatic and immunoturbidimetric methods.

Main Results:

• Pre-eclamptic women exhibited significantly higher maternal levels of TChol, LDLc, HDLc, TG, apoA-I, and apoB compared to healthy controls.
• UCB from pre-eclamptic pregnancies showed significantly lower HDLc and apoA-I, but higher TG concentrations and LDLc/HDLc ratio.
• Maternal TG levels positively correlated with proteinuria, a marker of PE severity.

Conclusions:

• Pre-eclamptic pregnancy is associated with enhanced maternal hyperlipidemia.
• This maternal hyperlipidemia negatively affects fetal lipid profiles, indicated by an increased atherogenic LDLc/HDLc ratio and higher TG levels in neonates.
• Infants born to mothers with PE may benefit from closer long-term clinical follow-up due to potential lipid-related health risks.